Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392

Watchlist Manager
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Logo
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Watchlist
Price: 62.9 CNY -1.93% Market Closed
Market Cap: 79.6B CNY

Wall Street
Price Targets

Price Targets Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Wall Street analysts forecast Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 61.35 CNY with a low forecast of 46.46 CNY and a high forecast of 78.02 CNY.

Lowest
Price Target
46.46 CNY
26% Downside
Average
Price Target
61.35 CNY
2% Downside
Highest
Price Target
78.02 CNY
24% Upside
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors:
Price Targets
PRTC
PureTech Health PLC
271% Upside
LXRX
Lexicon Pharmaceuticals Inc
265% Upside
ATYR
aTyr Pharma Inc
260% Upside
2171
CARsgen Therapeutics Holdings Ltd
58% Downside
BCRX
BioCryst Pharmaceuticals Inc
78% Upside
4882
Perseus Proteomics Inc
103% Upside
SLNO
Soleno Therapeutics Inc
41% Upside
4584
Kidswell Bio Corporation
38% Upside

Revenue
Forecast

Revenue Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

For the last 6 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is 15%. The projected CAGR for the next 2 years is 70%.

15%
Past Growth
70%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

For the last 6 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is -16%. The projected CAGR for the next 2 years is 302%.

-16%
Past Growth
302%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's stock price target?
Price Target
61.35 CNY

According to Wall Street analysts, the average 1-year price target for Beijing Wantai Biological Pharmacy Enterprise Co Ltd is 61.35 CNY with a low forecast of 46.46 CNY and a high forecast of 78.02 CNY.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Revenue forecast?
Projected CAGR
70%

For the last 6 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is 15%. The projected CAGR for the next 2 years is 70%.

What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Net Income forecast?
Projected CAGR
302%

For the last 6 years the compound annual growth rate for Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is -16%. The projected CAGR for the next 2 years is 302%.

Back to Top